Meneses-García A, Herrera J, Mohar A, García-Cuellar C, Súchil-Bernal L

Language: Spanish
References: 40
Page: 291-296
PDF size: 75.70 Kb.

ABSTRACT

Twenty cases of extraganglionar Nasal-type T/NK-cell lymphomas were analyzed at the National Cancer Institute of Mexico. We studied immunophenotype of neoplastic cells, nuclear p53 expression, and enzymes as matrix metalloproteinases participating in invasion, tissular destruction and metastases.
Material and Methods: Paraffin blocks from all cases were retrieved and analyzed by hematoxilin and eosin. Histopathological features included cellular size and cytologic characteristics. We performed immunohisto-chemistry to determine CD3, CD56, p53 cellular type and expression of (MMPs-1, 2,11) matrix metalloproteinases and one tissue inhibitor of TIMP-1 metalloproteinase. Demographic variables included, age, sex, primary location, clinical stage, treatment and follow-up.
Statistical analysis: The association of different matrix metalloproteinases in epithelial and tumoral cells, stroma, necrosis and endothelial cells were found to be significant using Fisher´s exact test.
Results: All studied cases were positive to cytoplasmic CD3, CD56 (NK cells), 19 of them were positive to p53, five of them with nuclear overexpression of p53 in more than 50% of neoplastic cells. There was significant expression of MMP-1 in tumoral cells; the epithelium displayed significant expression of TIMP-1 and MMP-11. Patients with p53 overexpression displayed a poorer prognosis. Three of them had undergone radiotherapy and died within the first month of treatment.
Discussion: This type of lymphoma is a common neoplasm in Asia, Latin America and Mexico. It is worth noting it has has been linked to Epstein-Barr virus with T/NK-cell phenotype, which often displays cellular atypia, an angiocentric growth pattern and necrosis. It is clinically expressed by progressive destruction of midline facial soft tissue and has a poor prognosis.

REFERENCES

1. Jaffe ES, Chan JKC, Su IJ, Frizzera G, Mori S, Séller AC, et al. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103-111.

2. 2. Meneses A, Zarate A, Sobrevilla P, Reynoso E, Ochoa F, Gómez E, et al. Linfoma angiocéntrico centrofacial (reticulosis polimorfa). Estudio clínico patológico de 35 casos. Patología 1993;31:163-168.

3. 3. Eichel BS, Harrison EG, Devine KP, Scaton PW, Brown HA. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 1966;12:597-605.

4. 4. Chan JKC, NG CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987;11:418-429.

5. 5. Yung YW, Jeffery CB, Stewart DDS, Kratochvil J, Zieper MB. Angiocentric T-cell lymphoma presenting as midface destructive lesion: Case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:353-60.

6. 6. Yuen A, Jacobs CH. Lymphoma of the head and neck. Semin Oncol 1999;26:338-345.

7. 7. Ho FC, Choy D, Loke S, Kung I, Fu K, Liang R, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases and immunophenotypic studies of 16 cases. Hum Pathol 1990;21:1041-1050.

8. 8. Ye YL, Zhou MH, Lu XY et al. Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology 1992;20:511-516.

9. 9. Ratech H, Burke JS, Blayney DW, Sheibani K, Rappaport H. A clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses and hard palate including cases of lethal midline granuloma. Cancer 1989;64:2525-2531.

10. Aozasa K, Ohsawa M, Tajima K, Sasaki R, Maeda H, Matsunaga T, et al. Nation-wide study of letal mid-line granuloma in Japan: frequencies of Wegener´s granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989;44:63-66.

11. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period. Int J Cancer 1984;34:143-148.

12. Ng CS, Chan JKC, Lo STH, Poon YF. Immunophenotypic analysis of non-Hodgkin´s lymphomas in Chinese: a study of 75 cases in Hong Kong. Pathology 1986;18:419-425.

13. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 1993;17:392-399.

14. Navarro-Roman L, Zarate-Osorno A, Meneses-García A, Kingma DW, Jaffe ES. High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico. Mod Pathol 1994;7:117A.

15. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in “Western” sinonasal and Waldeyer´s ring non-Hodgkin´s lymphomas. Am J Surg Pathol 1992;16:156-162.

16. Van Gorp J, Weiping L, Jacobse K, Yong HL, Feng-Yuan L, De Weger RA, et al. Epstein-Barr virus in nasal T-cell lymphomas (Polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 1994;173:81-87.

17. Jaffe ES. Nasal and nasal/type NK/T cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995;27:581-583.

18. Elenitoba-Johnson KSJ, Zarate-Osorno A, Meneses-García A, Krenacs L, Kingma DW, Raffeld M, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 1998;11:754-761.

19. Chan JKC, Jaffe ES, Ralklaer E. Extranodal NK/T cell lymphoma, Nasal type. Pathology and genetics of tumours of Haematopoietic and Lymphoid Tissues. Edit by ES Jaffe, NL Harris, H Stein, JW Vardiman. Lyon, World Health Organization Classification of Tumours and IARC Press, 2001, pp 204-207.

20. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Clearly ML, Delsol G, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.

21. Kusukawa J, Sasaguriy, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymphoid node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993;99:18-23.

22. Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992;14: 455-463.

23. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-572.

24. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathological study. Am J Clin Pathol 1993;99:18-23.

25. Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, et al. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 1998;17:295-301.

26. Gonzalez-Avila G, Iturria C, Vadillo F, Teran L, Selman M, Perez-Tamayo R. 72 kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. Pathobiology 1998;66:5-16.

27. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 1993;5:19-28

28. Kossakowska AE, Urbanski SJ, Edwards DR. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin´s lymphomas. Blood 1991;77:2475-2481.

29. Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin´s lymphomas. Blood 199;94:2080-2089.

30. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin´s lymphomas in humans. Br J Cancer 1996;73:1401-1408.

31. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991;88: 5413-5417.

32. Quintanilla-Martínez L, Franklin JL, Guerrero I, Krenacs L, Naresh KN, Rama-Rao C, et al. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol 1999;30:849-855.

33. Li T, Hongyo T, Syaidufin M, Nomura T, Dong Z, Shingu N, Kojya S, et al. mutations of the p53 gene in nasal NK/Tcell lymphoma. Lab Invest 2000;80:493-499.

34. Quintanilla-Martinez L, Kremer M, Keller G, Nathrath M, Gamboa-Dominguez A, Meneses Abelardo, et al. Fend Falko. p53 mutations in nasal natural killer/T-cell lymphoma from Mexico. Association with large cell morphology and advanced disease. Am J Pathol 2001;159:2095-2105.

35. Chan ACL, Ho JWY, Chiang AKS, Srivastava G. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology 1999;34:16-24.

36. Myamoto T, Yoshino T, Takehisa Y, Hagari Y, Mimara M. Cutaneous presentation of nasal-type T/NK cell lymphoma: clinicopathological findings of 4 cases. Br J Dermatol 1998;139:481-486.

37. Dano K, Romer J, Nielsen B, Bjorn S, Pyke C, Rygaard J, et al. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS 1999;107:120-127.

38. Romanic AM, Madri JA. The induction of 72-kD gelatinase in T cells upon adhesion to endotelial cells is VCAM-1 dependent. J Cell Biol 1994;125:1165-1169.

39. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.

40. Sun Y, Wicha M, Leopold WR. Regulation of metastasis-related gene expression by p53: a potential clinical implication. Mol Carcinog 1999;24:25-28